glp 1 serena williams Opens Up About Being on a GLP-1 EXCLUSIVE: Serena Williams has been

This report examines ColonBroom GLP-1 Booster as one example within the non-prescription supplement category, focusing on ingredient disclosures, regulatory context, and research framing

Semaglutide is a widely popular GLP-1 receptor agonist used for the management of type 2 diabetes and obesity

Ozempic face, which happens when theres rapid loss of fat in the face, and might cause sunken eyes, hollow appearance, wrinkles, or sagging

104 Cotadutide by AstraZeneca and efinopegdutide by Merck Sharp & Dohme are other GLP-1R/GCGR dual agonists

While GLP-1 RA prevalence among non-diabetic adults held steady at 0.1% from 2018-2021, it quadrupled to 0.4% in 2022 alone

That said, this is still emerging research, and more is needed to fully understand the long-term effects and potential of GLP-1 medications for different populations